Posted On: 10/01/2015 11:36:23 PM
Post# of 30038
Slide 28 mentions Lympro partnerships.
If fact right before, at 31:54, they said they are evaluating strategic transactions (not options). At that point you here someone gasp in the audience. I don't think they fell over as I didn't hear a follow on thud.
I won't mention that MSPrecise is targeted to have CLIA in Q4 with a 2.2B opp.
If fact right before, at 31:54, they said they are evaluating strategic transactions (not options). At that point you here someone gasp in the audience. I don't think they fell over as I didn't hear a follow on thud.
I won't mention that MSPrecise is targeted to have CLIA in Q4 with a 2.2B opp.
(0)
(0)Scroll down for more posts ▼
